About company
They are a blank check company formed under the laws of the State of Delaware April 19, 2021. They were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which they refer to throughout this prospectus as their initial business combination. Although there is no restriction or limitation on what industry their target operates in, it is their intention to pursue prospective targets that are focused on healthcare innovation. They anticipate targeting what are traditionally known as “small cap” companies domiciled in North America, Europe and/or the Asia Pacific (“APAC”) regions that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space which aligns with their management team’s experience in operating health care companies and in drug and device technology development as well as diagnostic and other services At the time of preparing this prospectus, they have not identified any specific business combination, nor has anyone on their behalf initiated or engaged in any substantive discussions, formal or otherwise, related to such a transaction. Their efforts to date are limited to organizational activities related to this offering.